CheckMate 8HW: Excellent results for nivolumab plus ipilimumab in MSI-H/dMMR mCRC Presented ByProf. Thierry André, Sorbonne University, France TrialPhase 3, CheckMate 8HW ConferenceASCO GI 2024 13 February, 2024 12:44